Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Good
|
|
New words:
adulterated, advice, answered, arrest, built, Cartesia, category, CeloNova, Chancery, chemotherapy, choose, CID, clarify, classification, collaboration, committee, context, counterclaim, counterfeit, CPI, deceptive, declaration, declaratory, Department, DOJ, Edward, EnduraLife, enrichment, equitable, fiduciary, Flutter, FLX, focused, foundational, framework, fulfillment, fundamental, Grand, handling, harmed, immaterial, Indiana, IntellaNav, invading, investigational, Investigative, Irrigated, Julio, Justice, LAAC, labeling, lease, leasing, led, loaded, located, longest, Mackey, Maryland, medicine, Medizintechnik, MiFi, Mirowski, misrepresentation, Montgomery, Neural, newest, noncurrent, OI, orderly, overturn, owed, pancreatic, PCI, platform, promised, promote, proprietary, purpose, PVT, Qingsheng, qualified, quantitative, Quincy, radiology, readily, reconsideration, rejected, remeasured, repaid, repositionable, resin, retroactively, Sadra, SAS, shipping, Shortly, Spenser, spherical, Spinelli, sudden, suspended, suspension, TAVR, team, Teresa, thinnest, touching, transmural, undergoing, unjust, upcode, USPTO, uterine, vaginal, valid, vasculature, verdict, voltage, voluntarily, Zhu
Removed:
achieved, acted, added, Additionally, ADVANTIO, amendment, AngioJet, announcement, Aspiration, AUTOGEN, automating, banc, bench, blocked, blood, Bonzel, BSSA, calculated, Certiorari, challenging, clearance, closed, commence, commenced, commit, compatible, competitor, conjunction, conspiracy, convergence, count, criteria, de, dealing, deduction, denervation, differentiated, diluted, discontinued, diseased, divested, eliminated, en, encouraged, endovascular, environment, Euro, evidence, exhibit, exiting, expanded, factual, faith, feedback, Fetch, Flex, Food, force, FORMIO, found, functional, German, Greece, gynecological, head, header, HOT, hypertension, hysteroscopic, IASB, ImageReady, importing, improper, improperly, inducing, inefficiency, INGENIO, interfered, interference, intrauterine, involvement, IoGyn, Iraq, Italia, Italian, Italy, JetStream, job, jurisdictional, Kassel, kind, leveraging, Luigi, measuring, meet, metric, Milan, mix, MK, month, Neurovascular, nonrecurring, NXT, Oil, operation, opposed, party, petition, Pfizer, phase, plaque, Portugal, preferred, prejudice, premarket, pulse, punitive, reached, receipt, refile, refiled, rehearing, relocating, remedy, removal, renal, Republic, repurchased, request, resistant, retention, RhythmiaTM, Schneider, separation, set, shared, Spain, specificity, spending, standardizing, standing, Stryker, suite, Supreme, SymphionTM, Tassilo, Tellini, Thrombectomy, thrombi, tortiously, TX, upfront, Vessix, VessixTM, VITALIO, wirelessly, Writ, York
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Exhibit 10.1 - E. Mackey Offer Letter 12.24.14
- 10.2 Exhibit 10.2 - Form of Nqso Agreement - Approved 2016
- 10.3 Exhibit 10.3 - Form of Dsu Agreement - Approved 2016
- 10.4 Exhibit 10.4 - 2016 Psu TSR
- 10.5 Exhibit 10.5 - 2016 Psu FCF
- 31.1 Exhibit 31.1 - CEO 302 Q1 2016
- 31.2 Exhibit 31.2 - CFO 302 Q1 2016
- 32.1 Exhibit 32.1 - CEO 906 Q1 2016
- 32.2 Exhibit 32.2 - CFO 906 Q1 2016
- Download Excel data file
- View Excel data file
Related press release
BSX similar filings
Filing view
External links
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Boston Scientific Corporation (the “Company”) for the period ending March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation. | |
This certification shall not be deemed "filed" for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.
| By: | /s/ Daniel J. Brennan | |
| Daniel J. Brennan | ||
| Executive Vice President and Chief Financial Officer | ||
| May 4, 2016 | ||